Showing results (81-90 of 516) with videos related to
Sort By:
Pageof 52
The Journal of Antimicrobial Chemotherapy|December 1, 2021
In vitro activity of the orally bioavailable ceftibuten/VNRX-7145 (VNRX-5236 etzadroxil) combination against a challenge set of Enterobacterales pathogens carrying molecularly characterized β-lactamase genesRodrigo E Mendes, Paul R Rhomberg, Amy A Watters, et al.The Journal of Antimicrobial Chemotherapy|July 31, 2018
Frequency and antimicrobial susceptibility of Gram-negative bacteria isolated from patients with pneumonia hospitalized in ICUs of US medical centres (2015-17)Helio S Sader, Mariana Castanheira, Rodrigo E Mendes, et al.Microbial Drug Resistance (Larchmont, N.Y.)|August 19, 2008
Rapid emergence of blaCTX-M among Enterobacteriaceae in U.S. Medical Centers: molecular evaluation from the MYSTIC Program (2007)Mariana Castanheira, Rodrigo E Mendes, Paul R Rhomberg, et al.Diagnostic Microbiology and Infectious Disease|November 22, 2008
United States resistance surveillance results for linezolid (LEADER Program for 2007)Ronald N Jones, James E Ross, Mariana Castanheira, et al.Journal of Chemotherapy (Florence, Italy)|March 8, 2019
Distribution of main Gram-positive pathogens causing bloodstream infections in United States and European hospitals during the SENTRY Antimicrobial Surveillance Program (2010-2016): concomitant analysis of oritavancin in vitro activityRodrigo E Mendes, Helio S Sader, Mariana Castanheira, et al.Antimicrobial Agents and Chemotherapy|January 13, 2025
Ceftobiprole activity against multidrug-resistant Staphylococcus aureus clinical isolates collected in the United States from 2016 through 2022Helio S Sader, Jennifer I Smart, Rodrigo E Mendes, et al.Antibiotics (Basel, Switzerland)|April 27, 2026
In Vitro Antimicrobial Activity of Ceftobiprole and Comparator Agents Against Streptococcus pneumoniae Responsible for Lower Respiratory Tract Infections in the United States (2016-2020), Including Resistant Subsets and Select SerotypesHelio S Sader, Mariana Castanheira, Mark E Jones, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 7, 2011
In vitro antimicrobial findings for fusidic acid tested against contemporary (2008-2009) gram-positive organisms collected in the United StatesRonald N Jones, Rodrigo E Mendes, Helio S Sader, et al.Journal of Clinical Microbiology|April 1, 1977
Cellular immunity in chronic Chagas' diseaseO M Montufar, C C Musatti, E Mendes, et al.Diagnostic Microbiology and Infectious Disease|October 24, 2022
Update on the in vitro activity of ceftaroline against Staphylococcus aureus from United States (US) medical centers stratified by infection type (2018-2020)Helio S Sader, Mariana Castanheira, Leonard R Duncan, et al.Pageof 52